Sign in
4

Changes in Ownership

Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-043304

Chief Medical Officer sold 28,699 shares at $4.83 ($138,616)

  • Chief Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goldenberg Gary · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-21 Grant or award : show line 1 in the form +75,000 98,809 D
2023-07-24 Sale : show line 2 in the form −28,699 $4.83 $138,616 70,110 D
Open-market sales · 28,699 sh · avg $4.83 · $138,616
Loading xslF345X05/doc4.xml…